Shoulder Innovations Projects 2026 Net Revenue of $68M-$70M Following InSet Go Launch
Shoulder Innovations (NYSE: SI) reported strong growth and execution during its third quarter, highlighted by the successful launch of its next-generation glenoid implant, InSet Go. Management expressed confidence in the company's trajectory, citing robust operational performance as a key driver for upcoming fiscal periods. Looking ahead, the company has provided revenue guidance projecting net sales between $68 million and $70 million for 2026. Furthermore, Shoulder Innovations is advancing its product pipeline with plans to target an FDA submission for the InSet Neo implant in the first half of 2027.
Tickers: $SI
Topics: earnings report growth execution product launch
Read the full article at Seeking Alpha
Part of the story Shoulder Innovations projects $68M-$70M 2026 net revenue as InSet Go launches and InSet Neo targets H1 2027 FDA submission (2 articles)